CRISPR-based technologies: Prokaryotic defense weapons repurposed

Trends in Genetics

Volumn 30, Issue 3, 2014, Pages 111-118

  Terns, Rebecca M ^a   Terns, Michael P ^a,b  

^a University of Georgia ^*  (United States)

^b UNIVERSITY OF GEORGIA   (United States)

Author keywords

Biotechnology; Cas; CRISPR; Genome editing; Metabolic engineering; RNA silencing

Indexed keywords

CELLULAR APOPTOSIS SUSCEPTIBILITY PROTEIN; DNA; GUIDE RNA; RIBONUCLEASE; ZINC FINGER NUCLEASE;

BIOGENESIS; CRISPR CAS SYSTEM; DNA BINDING; DNA CLEAVAGE; DNA END JOINING REPAIR; GENE EXPRESSION; GENE FUNCTION; GENE SILENCING; GENE TARGETING; HUMAN; METABOLIC ENGINEERING; MICROBIAL IMMUNITY; NONHUMAN; PRIORITY JOURNAL; PROTEIN RNA BINDING; REVIEW; ANIMAL; CLUSTERED REGULARLY INTERSPACED SHORT PALINDROMIC REPEAT; GENETIC PROCEDURES; GENETICS; METABOLISM; PROKARYOTIC CELL; RNA EDITING;

PROKARYOTA;

ANIMALS; CLUSTERED REGULARLY INTERSPACED SHORT PALINDROMIC REPEATS; CRISPR-CAS SYSTEMS; ENDORIBONUCLEASES; GENETIC TECHNIQUES; HUMANS; PROKARYOTIC CELLS; RNA EDITING;

EID: 84896731736     PISSN: 01689525     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.tig.2014.01.003     Document Type: Review

References (122)

1. Hatfull G.F. Bacteriophage genomics. Curr. Opin. Microbiol. 2008, 11:447-453.
2. Labrie S.J., et al. Bacteriophage resistance mechanisms. Nat. Rev. Microbiol. 2010, 8:317-327.
3. Stern A., Sorek R. The phage-host arms race: shaping the evolution of microbes. Bioessays 2011, 33:43-51.
4. Westra E.R., et al. The CRISPRs, they are a-changin': how prokaryotes generate adaptive immunity. Annu. Rev. Genet. 2012, 46:311-339.
5. Samson J.E., et al. Revenge of the phages: defeating bacterial defences. Nat. Rev. Microbiol. 2013, 11:675-687.
6. Sorek R., et al. CRISPR-mediated adaptive immune systems in bacteria and archaea. Annu. Rev. Biochem. 2013, 82:237-266.
7. Terns M.P., Terns R.M. CRISPR-based adaptive immune systems. Curr. Opin. Microbiol. 2011, 14:321-327.
8. Bhaya D., et al. CRISPR-Cas systems in bacteria and archaea: versatile small RNAs for adaptive defense and regulation. Annu. Rev. Genet. 2011, 45:273-297.
9. Wiedenheft B., et al. RNA-guided genetic silencing systems in bacteria and archaea. Nature 2012, 482:331-338.
10. Haft D.H., et al. A guild of 45 CRISPR-associated (Cas) protein families and multiple CRISPR/Cas subtypes exist in prokaryotic genomes. PLoS Comput. Biol. 2005, 1:e60.
11. Makarova K.S., et al. Evolution and classification of the CRISPR-Cas systems. Nat. Rev. Microbiol. 2011, 9:467-477.
12. Chylinski K., et al. The tracrRNA and Cas9 families of type II CRISPR-Cas immunity systems. RNA Biol. 2013, 10:726-737.
13. Fonfara I., et al. Phylogeny of Cas9 determines functional exchangeability of dual-RNA and Cas9 among orthologous type II CRISPR-Cas systems. Nucleic Acids Res. 2013, 10.1093/nar/gkt1074.
14. Makarova K.S., et al. A putative RNA-interference-based immune system in prokaryotes: computational analysis of the predicted enzymatic machinery, functional analogies with eukaryotic RNAi, and hypothetical mechanisms of action. Biol. Direct 2006, 1:7.
15. Marraffini L.A., Sontheimer E.J. CRISPR interference limits horizontal gene transfer in staphylococci by targeting DNA. Science 2008, 322:1843-1845.
16. Garneau J.E., et al. The CRISPR/Cas bacterial immune system cleaves bacteriophage and plasmid DNA. Nature 2010, 468:67-71.
17. Gasiunas G., et al. Cas9-crRNA ribonucleoprotein complex mediates specific DNA cleavage for adaptive immunity in bacteria. Proc. Natl. Acad. Sci. U.S.A. 2012, 109:E2579-E2586.
18. Jinek M., et al. A programmable dual-RNA-guided DNA endonuclease in adaptive bacterial immunity. Science 2012, 337:816-821.
19. Fischer S., et al. An archaeal immune system can detect multiple protospacer adjacent motifs (PAMs) to target invader DNA. J. Biol. Chem. 2012, 287:33351-33363.
20. Gudbergsdottir S., et al. Dynamic properties of the Sulfolobus CRISPR/Cas and CRISPR/Cmr systems when challenged with vector-borne viral and plasmid genes and protospacers. Mol. Microbiol. 2011, 79:35-49.
21. Manica A., et al. In vivo activity of CRISPR-mediated virus defence in a hyperthermophilic archaeon. Mol. Microbiol. 2011, 80:481-491.
22. Zhang J., et al. Structure and mechanism of the CMR complex for CRISPR-mediated antiviral immunity. Mol. Cell 2012, 45:303-313.
23. Hale C.R., et al. RNA-guided RNA cleavage by a CRISPR RNA-Cas protein complex. Cell 2009, 139:945-956.
24. Hale C.R., et al. Essential features and rational design of CRISPR RNAs that function with the Cas RAMP module complex to cleave RNAs. Mol. Cell 2012, 45:292-302.
25. Spilman M., et al. Structure of an RNA silencing complex of the CRISPR-Cas immune system. Mol. Cell 2013, 52:146-152.
26. Staals R.H., et al. Structure and activity of the RNA-targeting type III-B CRISPR-Cas complex of Thermus thermophilus. Mol. Cell 2013, 52:135-145.
27. Barrangou R., et al. CRISPR provides acquired resistance against viruses in prokaryotes. Science 2007, 315:1709-1712.
28. Datsenko K.A., et al. Molecular memory of prior infections activates the CRISPR/Cas adaptive bacterial immunity system. Nat. Commun. 2012, 3:945.
29. Erdmann S., Garrett R.A. Selective and hyperactive uptake of foreign DNA by adaptive immune systems of an archaeon via two distinct mechanisms. Mol. Microbiol. 2012, 85:1044-1056.
30. Swarts D.C., et al. CRISPR interference directs strand specific spacer acquisition. PLoS ONE 2012, 7:e35888.
31. Yosef I., et al. Proteins and DNA elements essential for the CRISPR adaptation process in Escherichia coli. Nucleic Acids Res. 2012, 40:5569-5576.
32. Brouns S.J., et al. Small CRISPR RNAs guide antiviral defense in prokaryotes. Science 2008, 321:960-964.
33. Carte J., et al. Binding and cleavage of CRISPR RNA by Cas6. RNA 2010, 16:2181-2188.
34. Carte J., et al. Cas6 is an endoribonuclease that generates guide RNAs for invader defense in prokaryotes. Genes Dev. 2008, 22:3489-3496.
35. Deltcheva E., et al. CRISPR RNA maturation by trans-encoded small RNA and host factor RNase III. Nature 2011, 471:602-607.
36. Garside E.L., et al. Cas5d processes pre-crRNA and is a member of a larger family of CRISPR RNA endonucleases. RNA 2012, 18:2020-2028.
37. Hatoum-Aslan A., et al. Mature clustered, regularly interspaced, short palindromic repeats RNA (crRNA) length is measured by a ruler mechanism anchored at the precursor processing site. Proc. Natl. Acad. Sci. U.S.A. 2011, 108:21218-21222.
38. Haurwitz R.E., et al. Sequence- and structure-specific RNA processing by a CRISPR endonuclease. Science 2010, 329:1355-1358.
39. Hale C., et al. Prokaryotic silencing (psi)RNAs in Pyrococcus furiosus. RNA 2008, 14:2572-2579.
40. Lintner N.G., et al. Structural and functional characterization of an archaeal clustered regularly interspaced short palindromic repeat (CRISPR)-associated complex for antiviral defense (CASCADE). J. Biol. Chem. 2011, 286:21643-21656.
41. Wiedenheft B., et al. Structures of the RNA-guided surveillance complex from a bacterial immune system. Nature 2011, 477:486-489.
42. Wiedenheft B., et al. RNA-guided complex from a bacterial immune system enhances target recognition through seed sequence interactions. Proc. Natl. Acad. Sci. U.S.A. 2011, 108:10092-10097.
43. Jore M.M., et al. Structural basis for CRISPR RNA-guided DNA recognition by Cascade. Nat. Struct. Mol. Biol. 2011, 18:529-536.
44. Beloglazova N., et al. Structure and activity of the Cas3 HD nuclease MJ0384, an effector enzyme of the CRISPR interference. EMBO J. 2011, 30:4616-4627.
45. Sinkunas T., et al. Cas3 is a single-stranded DNA nuclease and ATP-dependent helicase in the CRISPR/Cas immune system. EMBO J. 2011, 30:1335-1342.
46. Sapranauskas R., et al. The Streptococcus thermophilus CRISPR/Cas system provides immunity in Escherichia coli. Nucleic Acids Res. 2011, 39:9275-9282.
47. Horvath P., et al. Applications of the versatile CRISPR-Cas systems. CRISPR-Cas Systems: RNA-mediated Adative Immunity in Bacteria and Archaea 2012, 267-278. Springer-Verlag. R. Barrangou, J. van der Oost (Eds.).
48. Pennisi E. The CRISPR craze. Science 2013, 341:833-836.
49. Richter H., et al. Exploiting CRISPR/Cas: interference mechanisms and applications. Int. J. Mol. Sci. 2013, 14:14518-14531.
50. Andersson A.F., Banfield J.F. Virus population dynamics and acquired virus resistance in natural microbial communities. Science 2008, 320:1047-1050.
51. Barrangou R., Horvath P. CRISPR: new horizons in phage resistance and strain identification. Annu. Rev. Food Sci. Technol. 2012, 3:143-162.
52. Shariat N., et al. The combination of CRISPR-MVLST and PFGE provides increased discriminatory power for differentiating human clinical isolates of Salmonella enterica subsp. enterica serovar Enteritidis. Food Microbiol. 2013, 34:164-173.
53. Delannoy S., et al. Use of clustered regularly interspaced short palindromic repeat sequence polymorphisms for specific detection of enterohemorrhagic Escherichia coli strains of serotypes O26:H11, O45:H2, O103:H2, O111:H8, O121:H19, O145:H28, and O157:H7 by real-time PCR. J. Clin. Microbiol. 2012, 50:4035-4040.
54. Stern A., et al. CRISPR targeting reveals a reservoir of common phages associated with the human gut microbiome. Genome Res. 2012, 22:1985-1994.
55. Shariat N., Dudley E.G. CRISPRs: molecular signatures used for pathogen subtyping. Appl. Environ. Microbiol. 2014, 80:430-439.
56. Elmore J.R., et al. Programmable plasmid interference by the CRISPR-Cas system in Thermococcus kodakarensis. RNA Biol. 2013, 10:828-840.
57. Pougach K., et al. Transcription, processing and function of CRISPR cassettes in Escherichia coli. Mol. Microbiol. 2010, 77:1367-1379.
58. Urnov F.D., et al. Genome editing with engineered zinc finger nucleases. Nat. Rev. Genet. 2010, 11:636-646.
59. Perez-Pinera P., et al. Advances in targeted genome editing. Curr. Opin. Chem. Biol. 2012, 16:268-277.
60. Joung J.K., Sander J.D. TALENs: a widely applicable technology for targeted genome editing. Nat. Rev. Mol. Cell Biol. 2013, 14:49-55.
61. Gasiunas G., Siksnys V. RNA-dependent DNA endonuclease Cas9 of the CRISPR system: Holy Grail of genome editing?. Trends Microbiol. 2013, 21:562-567.
62. Mali P., et al. Cas9 as a versatile tool for engineering biology. Nat. Methods 2013, 10:957-963.
63. Jinek M., et al. RNA-programmed genome editing in human cells. eLife 2013, 2:e00471.
64. Cho S.W., et al. Targeted genome engineering in human cells with the Cas9 RNA-guided endonuclease. Nat. Biotechnol. 2013, 31:230-232.
65. Cong L., et al. Multiplex genome engineering using CRISPR/Cas systems. Science 2013, 339:819-823.
66. Mali P., et al. RNA-guided human genome engineering via Cas9. Science 2013, 339:823-826.
67. Hou Z., et al. Efficient genome engineering in human pluripotent stem cells using Cas9 from Neisseria meningitidis. Proc. Natl. Acad. Sci. U.S.A. 2013, 110:15644-15649.
68. Ebina H., et al. Harnessing the CRISPR/Cas9 system to disrupt latent HIV-1 provirus. Sci. Rep. 2013, 3:2510.
69. Ran F.A., et al. Double nicking by RNA-guided CRISPR Cas9 for enhanced genome editing specificity. Cell 2013, 154:1380-1389.
70. Fu Y., et al. High-frequency off-target mutagenesis induced by CRISPR-Cas nucleases in human cells. Nat. Biotechnol. 2013, 31:822-826.
71. Hsu P.D., et al. DNA targeting specificity of RNA-guided Cas9 nucleases. Nat. Biotechnol. 2013, 31:827-832.
72. Cradick T.J., et al. CRISPR/Cas9 systems targeting beta-globin and CCR5 genes have substantial off-target activity. Nucleic Acids Res. 2013, 41:9584-9592.
73. Schwank G., et al. Functional repair of CFTR by CRISPR/Cas9 in intestinal stem cell organoids of cystic fibrosis patients. Cell Stem Cell 2013, 13:653-658.
74. Shalem O., et al. Genome-scale CRISPR-Cas9 knockout screening in human cells. Science 2014, 343:84-87.
75. Wang T., et al. Genetic screens in human cells using the CRISPR-Cas9 system. Science 2014, 343:80-84.
76. Li W., et al. Simultaneous generation and germline transmission of multiple gene mutations in rat using CRISPR-Cas systems. Nat. Biotechnol. 2013, 31:684-686.
77. Li D., et al. Heritable gene targeting in the mouse and rat using a CRISPR-Cas system. Nat. Biotechnol. 2013, 31:681-683.
78. Yang H., et al. One-step generation of mice carrying reporter and conditional alleles by CRISPR/Cas-mediated genome engineering. Cell 2013, 154:1370-1379.
79. Wang H., et al. One-step generation of mice carrying mutations in multiple genes by CRISPR/Cas-mediated genome engineering. Cell 2013, 153:910-918.
80. Wu Y., et al. Correction of a genetic disease in mouse via use of CRISPR-Cas9. Cell Stem Cell 2013, 13:659-662.
81. Hwang W.Y., et al. Efficient genome editing in zebrafish using a CRISPR-Cas system. Nat. Biotechnol. 2013, 31:227-229.
82. Chang N., et al. Genome editing with RNA-guided Cas9 nuclease in zebrafish embryos. Cell Res. 2013, 23:465-472.
83. Jao L.E., et al. Efficient multiplex biallelic zebrafish genome editing using a CRISPR nuclease system. Proc. Natl. Acad. Sci. U.S.A. 2013, 110:13904-13909.
84. Xiao A., et al. Chromosomal deletions and inversions mediated by TALENs and CRISPR/Cas in zebrafish. Nucleic Acids Res. 2013, 41:e141.
85. Nakayama T., et al. Simple and efficient CRISPR/Cas9-mediated targeted mutagenesis in Xenopus tropicalis. Genesis 2013, 51:835-843.
86. Blitz I.L., et al. Biallelic genome modification in F0 Xenopus tropicalis embryos using the CRISPR/Cas system. Genesis 2013, 51:827-834.
87. Shan Q., et al. Targeted genome modification of crop plants using a CRISPR-Cas system. Nat. Biotechnol. 2013, 31:686-688.
88. Li J.F., et al. Multiplex and homologous recombination-mediated genome editing in Arabidopsis and Nicotiana benthamiana using guide RNA and Cas9. Nat. Biotechnol. 2013, 31:688-691.
89. Feng Z., et al. Efficient genome editing in plants using a CRISPR/Cas system. Cell Res. 2013, 23:1229-1232.
90. Miao J., et al. Targeted mutagenesis in rice using CRISPR-Cas system. Cell Res. 2013, 23:1233-1236.
91. Jiang W., et al. Demonstration of CRISPR/Cas9/sgRNA-mediated targeted gene modification in Arabidopsis, tobacco, sorghum and rice. Nucleic Acids Res. 2013, 41:e188.
92. Nekrasov V., et al. Targeted mutagenesis in the model plant Nicotiana benthamiana using Cas9 RNA-guided endonuclease. Nat. Biotechnol. 2013, 31:691-693.
93. Upadhyay S.K., et al. RNA-guided genome editing for target gene mutations in wheat. G3 2013, 3:2233-2238.
94. Bassett A.R., et al. Highly efficient targeted mutagenesis of Drosophila with the CRISPR/Cas9 System. Cell Rep. 2013, 4:220-228.
95. Gratz S.J., et al. CRISPR/Cas9-mediated genome engineering and the promise of designer flies on demand. Fly 2013, 7:249-255.
96. Gratz S.J., et al. Genome engineering of Drosophila with the CRISPR RNA-guided Cas9 nuclease. Genetics 2013, 194:1029-1035.
97. Yu Z., et al. Highly efficient genome modifications mediated by CRISPR/Cas9 in Drosophila. Genetics 2013, 195:289-291.
98. Kondo S., Ueda R. Highly improved gene targeting by germline-specific Cas9 expression in Drosophila. Genetics 2013, 195:715-721.
99. Sebo Z.L., et al. A simplified and efficient germline-specific CRISPR/Cas9 system for Drosophila genomic engineering. Fly 2013, 8:1-6.
100. Friedland A.E., et al. Heritable genome editing in C. elegans via a CRISPR-Cas9 system. Nat. Methods 2013, 10:741-743.
101. Lo T.W., et al. Precise and heritable genome editing in evolutionarily diverse nematodes using TALENs and CRISPR/Cas9 to engineer insertions and deletions. Genetics 2013, 195:331-348.
102. Waaijers S., et al. CRISPR/Cas9-targeted mutagenesis in Caenorhabditis elegans. Genetics 2013, 195:1187-1191.
103. Tzur Y.B., et al. Heritable custom genomic modifications in Caenorhabditis elegans via a CRISPR-Cas9 system. Genetics 2013, 195:1181-1185.
104. Katic I., Grosshans H. Targeted heritable mutation and gene conversion by Cas9-CRISPR in Caenorhabditis elegans. Genetics 2013, 195:1173-1176.
105. Chiu H., et al. Transgene-free genome editing in Caenorhabditis elegans using CRISPR-Cas. Genetics 2013, 195:1167-1171.
106. Dickinson D.J., et al. Engineering the Caenorhabditis elegans genome using Cas9-triggered homologous recombination. Nat. Methods 2013, 10:1028-1034.
107. Chen C., et al. Efficient genome editing in Caenorhabditis elegans by CRISPR-targeted homologous recombination. Nucleic Acids Res. 2013, 41:e193.
108. Wang Y., et al. The CRISPR/Cas system mediates efficient genome engineering in Bombyx mori. Cell Res. 2013, 23:1414-1416.
109. DiCarlo J.E., et al. Genome engineering in Saccharomyces cerevisiae using CRISPR-Cas systems. Nucleic Acids Res. 2013, 41:4336-4343.
110. Jiang W., et al. RNA-guided editing of bacterial genomes using CRISPR-Cas systems. Nat. Biotechnol. 2013, 31:233-239.
111. Mali P., et al. CAS9 transcriptional activators for target specificity screening and paired nickases for cooperative genome engineering. Nat. Biotechnol. 2013, 31:833-838.
112. Deveau H., et al. Phage response to CRISPR-encoded resistance in Streptococcus thermophilus. J. Bacteriol. 2008, 190:1390-1400.
113. Esvelt K.M., et al. Orthogonal Cas9 proteins for RNA-guided gene regulation and editing. Nat. Methods 2013, 10:1116-1121.
114. Qi L.S., et al. Repurposing CRISPR as an RNA-guided platform for sequence-specific control of gene expression. Cell 2013, 152:1173-1183.
115. Cheng A.W., et al. Multiplexed activation of endogenous genes by CRISPR-on, an RNA-guided transcriptional activator system. Cell Res. 2013, 23:1163-1171.
116. Farzadfard F., et al. Tunable and multifunctional eukaryotic transcription factors based on CRISPR/Cas. ACS Synth. Biol. 2013, 13:604-613.
117. Gilbert L.A., et al. CRISPR-mediated modular RNA-guided regulation of transcription in eukaryotes. Cell 2013, 154:442-451.
118. Bikard D., et al. Programmable repression and activation of bacterial gene expression using an engineered CRISPR-Cas system. Nucleic Acids Res. 2013, 41:7429-7437.
119. Pattanayak V., et al. High-throughput profiling of off-target DNA cleavage reveals RNA-programmed Cas9 nuclease specificity. Nat. Biotechnol. 2013, 31:839-843.
120. Qi L., et al. RNA processing enables predictable programming of gene expression. Nat. Biotechnol. 2012, 30:1002-1006.
121. Lee H.Y., et al. RNA-protein analysis using a conditional CRISPR nuclease. Proc. Natl. Acad. Sci. U.S.A. 2013, 110:5416-5421.
122. Salvail-Lacoste A., et al. Affinity purification of T7 RNA transcripts with homogeneous ends using ARiBo and CRISPR tags. RNA 2013, 19:1003-1014.